These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16926045)

  • 1. Thrombin generation assays: understanding how the method influences the results.
    Wolberg AS
    Thromb Res; 2007; 119(6):663-5. PubMed ID: 16926045
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro.
    Lau A; Berry LR; Mitchell LG; Chan AK
    Thromb Res; 2007; 119(6):667-77. PubMed ID: 16793122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.
    Devreese K; Wijns W; Combes I; Van kerckhoven S; Hoylaerts MF
    Thromb Haemost; 2007 Sep; 98(3):600-13. PubMed ID: 17849049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of the inhibitory effect of fondaparinux on thrombin generation by rFVIIa, aPCC and PCC.
    Desmurs-Clavel H; Huchon C; Chatard B; Negrier C; Dargaud Y
    Thromb Res; 2009 Mar; 123(5):796-8. PubMed ID: 18771795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific determination of plasmatic thrombin activity.
    Stief TW
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):324-9. PubMed ID: 16959686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC
    Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin.
    Gerotziafas GT; Dupont C; Spyropoulos AC; Hatmi M; Samama MM; Kiskinis D; Elalamy I
    Thromb Haemost; 2009 Jul; 102(1):42-8. PubMed ID: 19572066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do we need thrombin generation assays for monitoring anticoagulation?
    Dempfle CE; Borggrefe M
    Thromb Haemost; 2008 Aug; 100(2):179-80. PubMed ID: 18690334
    [No Abstract]   [Full Text] [Related]  

  • 9. The extrinsic coagulation activity assay.
    Stief TW; Wieczerzak A; Renz H
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):303-18. PubMed ID: 18586682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation testing in routine clinical practice: are we there yet?
    van Veen JJ; Gatt A; Makris M
    Br J Haematol; 2008 Sep; 142(6):889-903. PubMed ID: 18564356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of factor IIa inhibitors on the endogenous thrombin potential.
    Beilfuss A; Grandoch M; Wenzel F; Hohlfeld T; Schrör K; Weber AA
    Ther Drug Monit; 2008 Dec; 30(6):740-3. PubMed ID: 18824953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple procedure for specific assay of lipid hydroperoxides in serum or plasma.
    Yagi K
    Methods Mol Biol; 1998; 108():107-10. PubMed ID: 9921520
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombin generation in patients after acute deep-vein thrombosis.
    ten Cate-Hoek AJ; Dielis AW; Spronk HM; van Oerle R; Hamulyák K; Prins MH; ten Cate H
    Thromb Haemost; 2008 Aug; 100(2):240-5. PubMed ID: 18690343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring thrombin generation based sensitivity to activated protein C using an automated coagulometer (ACL 9000).
    Gardiner C; Machin SJ; Mackie IJ
    Int J Lab Hematol; 2008 Aug; 30(4):261-8. PubMed ID: 18665822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
    Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the action of factor VIIa in dilutional coagulopathy.
    Monroe DM
    Thromb Res; 2008; 122 Suppl 1():S7-S10. PubMed ID: 18691504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation.
    Lean SY; Ellery P; Ivey L; Thom J; Oostryck R; Leahy M; Baker R; Adams M
    Haematologica; 2006 Oct; 91(10):1360-6. PubMed ID: 17018385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo age dependency of unfractionated heparin in infants and children.
    Newall F; Ignjatovic V; Summerhayes R; Gan A; Butt W; Johnston L; Monagle P
    Thromb Res; 2009 Mar; 123(5):710-4. PubMed ID: 18829072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?
    Salvagno GL; Astermark J; Lippi G; Ekman M; Franchini M; Guidi GC; Berntorp E
    Haemophilia; 2009 Jan; 15(1):290-6. PubMed ID: 19149855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin generation: a comparison of assays using platelet-poor and -rich plasma and whole blood samples from healthy controls and patients with a history of venous thromboembolism.
    Tappenden KA; Gallimore MJ; Evans G; Mackie IJ; Jones DW
    Br J Haematol; 2007 Oct; 139(1):106-12. PubMed ID: 17854314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.